SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001324517-05-000008
Filing Date
2005-06-10
Accepted
2005-06-10 10:47:22
Documents
2
Period of Report
2005-06-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3/A  
1 PRIMARY DOCUMENT edgar.xml 3/A 3699
2 POWER OF ATTORNEY antczak1.htm EX-24 1134
  Complete submission text file 0001324517-05-000008.txt   6540
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Issuer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 383 COLOROW DRIVE SALT LAKE CITY X1 84108
Business Address 801-583-4939
Antczak Val R (Reporting) CIK: 0001324517 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-23272 | Film No.: 05888986